Therapy satisfaction and health literacy are key factors to improve medication adherence in systemic sclerosis
- 20 September 2022
- journal article
- research article
- Published by Taylor & Francis in Scandinavian Journal of Rheumatology
- Vol. 52 (4) , 395-402
Abstract
Although medication adherence (MA) contributes to therapeutic outcome in systemic sclerosis (SSc), research data are scarce. Factors influencing MA in SSc are hardly known. We conducted a monocentric, cross-sectional study on 85 patients with SSc at the University of Lübeck, Germany, using the Compliance Questionnaire of Rheumatology as the main measurement tool of MA. We also used the Scleroderma Health Assessment Questionnaire, Illness Perception Questionnaire – Revised, Health Literacy Questionnaire, Lübeck Medication Satisfaction Questionnaire (a novel instrument created for this study), and patients’ demographic and clinical data, to find factors contributing to MA. Good MA was seen in 51.8% of patients. MA was positively associated with therapy satisfaction (p < 0.001), modified Rodnan Skin Score (p = 0.032), age (p = 0.025), intake of micronutrients (p = 0.033), number of prescribed drugs (p = 0.014), and some dimensions of health literacy. Negative associations were found for patients with weight loss attributed to SSc (p = 0.009) and the perception that the disease is caused by the patient’s personality (p = 0.011) or emotional state (p = 0.037). Although most SSc patients display good MA, non-adherence remains a major problem. Patients should be assessed for non-adherence. The factors affecting MA identified herein could help to improve therapeutic outcomes.Keywords
Funding Information
- no specific grant from any funding agency in the public, commercial, or not-for-profit sectors
This publication has 35 references indexed in Scilit:
- The function of medication beliefs as mediators between personality traits and adherence behavior in people with asthmaPatient Preference and Adherence, 2013
- The grounded psychometric development and initial validation of the Health Literacy Questionnaire (HLQ)BMC Public Health, 2013
- Drug compliance in patients with systemic sclerodermaClinical Rheumatology, 2012
- Measures of systemic sclerosis (scleroderma): Health Assessment Questionnaire (HAQ) and Scleroderma HAQ (SHAQ), Physician‐ and Patient‐Rated Global Assessments, Symptom Burden Index (SBI), University of California, Los Angeles, Scleroderma Clinical Trials Consortium Gastrointestinal Scale (UCLA SCTC GIT) 2.0, Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) (Mahler's Index), Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR), and Raynaud's Condition Score (RCS)Arthritis Care & Research, 2011
- Personality and medication non‐adherence among older adults enrolled in a six‐year trialBritish Journal of Health Psychology, 2011
- Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) databaseAnnals of the Rheumatic Diseases, 2010
- The health assessment questionnaire disability index and scleroderma health assessment questionnaire in scleroderma trials: An evaluation of their measurement propertiesArthritis Care & Research, 2005
- Medication Non-Adherence in the ElderlyDrugs & Aging, 2004
- The Revised Illness Perception Questionnaire (IPQ-R)Psychology & Health, 2002
- RANDOMISED CLINICAL TRIAL OF STRATEGIES FOR IMPROVING MEDICATION COMPLIANCE IN PRIMARY HYPERTENSIONThe Lancet, 1975